July 18, 2024
13 min pay attention
On this version, atezolizumab advantages PD-L1-selected sufferers with NSCLC, dangers stick with e-cigarette use after quitting tobacco smoking and extra.
Learn the total protection right here:
Adjuvant atezolizumab advantages PD-L1-selected sufferers with NSCLC
Lung most cancers dangers stick with e-cigarette use after quitting tobacco smoking
COPD, IPF finish of life well being care use differs from lung most cancers
Tecentriq mixture fails to enhance survival in metastatic lung most cancers
Threat for lung most cancers reoccurrence could also be related to OSA-related hypoxemia
References:
Figueroa Rodriguez F, et al. 0468: CRASH: Most cancers reoccurrence is accelerated by episodic hypoxemia. Offered at: SLEEP; June 1-5, 2024; Houston.
Kim Y, et al. Affiliation of digital cigarette use after typical smoking cessation with lung most cancers threat: A nationwide cohort examine. Offered at: American Thoracic Society Worldwide Convention; Could 18-22, 2024; San Diego.
Wakelee HA, et al. Summary LBA8035. Offered at: ASCO Annual Assembly; Could 31-June 4, 2024; Chicago.

